Pharmaceutical

Mallinckrodt and Endo sign $6.7bn merger deal

The two companies are merging after previously filing for bankruptcy due to opioid-related litigation and financial losses.

Mar 15, 2025 - 06:00
Mallinckrodt and Endo sign $6.7bn merger deal
The two companies are merging after previously filing for bankruptcy due to opioid-related litigation and financial losses.
Read the original article

Tags:

Previous Article

Gedeon Richter’s once-daily endometriosis pill approved for NHS use

Next Article

Vivani treats first patient with long-lasting drug implant for weight loss

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Gedeptin by GeoVax Labs for Nasopharyngeal Cancer: Like...

Nov 16, 2023

STAT+: Senators start work on Medicare physician payment reform

STAT+: Senators start work on Medicare physician paymen...

Feb 9, 2024

STAT+: Karuna’s treatment for schizophrenia achieves study goals, bolsters FDA filing plans

STAT+: Karuna’s treatment for schizophrenia achieves st...

Mar 20, 2023